1921
Volume 77, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Ciguatoxins exert their effect on the voltage-sensitive sodium channels of the cellular membranes of all excitable tissues. This effect confers to ciguatera disease (CD) its neurologic hallmarks. A prospective study among French Polynesian adults over a two-month period was conducted to characterize and determine the persistence of neurologic symptoms of CD. We compared 47 patients with CD with 125 controls. In the acute phase of the disease, patients had mainly sensory disturbances as detected by an hypoesthesia on the palm of the hand and poorer sway performance compared with controls. Follow-up two months showed improvement of sway performance that eventually reaching control levels. However, for light-touch threshold, even if we observed a decrease threshold towards normal values, more than 50% of patients did not reach normal values 60 days after disease onset. Our results support the existence of neurologic impairments of CD and suggest their persistence for at least two months after onset.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.77.1170
2007-12-01
2017-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/77/6/0771170.html?itemId=/content/journals/10.4269/ajtmh.2007.77.1170&mimeType=html&fmt=ahah

References

  1. Park DL, Ayala CE, 1999. Reduction of Risks Associated with Foodborn Fungal and Aquatic Biotoxins: FEDRIP Database. Springfield, VA: National Technical Information Service.
  2. Baden D, Fleming L, Bean JA, 1995. Marines toxins. Wolff FA, ed. Handbook of Clinical Neurology: Intoxications of the Nervous System. II. Natural Toxins and Drugs. Amsterdam: Elsevier.
  3. Pearn J, 2001. Neurology of ciguatera. J Neurol Neurosurg Psychiatry 70 : 4–8.
  4. Butera R, Prockop LD, Buonocore M, Locatelli C, Gandini C, Manzo L, 2000. Mild ciguatera poisoning: case reports with neurophysiological evaluations. Muscle Nerve 23 : 1598–1603.
  5. Barton ED, Tanner P, Turchen SG, Tunget CL, Manoguerra A, Clark RF, 1995. Ciguatera fish poisoning. A southern California epidemic. West J Med 163 : 31–35.
  6. Chan TY, 1998. Lengthy persistence of ciguatoxin in the body. Trans R Soc Trop Med Hyg 92 : 662.
  7. Chretien JH, Fermaglich J, Garagusi VF, 1981. Ciguatera poisoning. Presentation as a neurologic disorder. Arch Neurol 38 : 783.
  8. Crump JA, McLay CL, Chambers ST, 1999. Ciguatera fish poisoning. Postgrad Med J 75 : 678–679.
  9. Derouiche F, Cohen E, Rodier G, Boulay C, Courtois S, 2000. Ciguatera and peripheral neuropathy: a case report. Rev Neurol (Paris) 156 : 514–516.
  10. Angibaud G, Leveque JM, Laurent D, Gaultier C, 2000. Neurological features after consumption of a variety of neo-Caledonian shellfish. Rev Neurol (Paris) 156 : 65–66.
  11. Angibaud G, Rambaud S, 1998. Serious neurological manifestations of ciguatera: is the delay unusually long? J Neurol Neurosurg Psychiatry 64 : 688–689.
  12. Morris JG Jr, Lewin P, Hargrett NT, Smith CW, Blake PA, Schneider R, 1982. Clinical features of ciguatera fish poisoning: a study of the disease in the US Virgin Islands. Arch Intern Med 142 : 1090–1092.
  13. Chan T, Kwok T, 2001. Chronicity of neurological features in ciguatera fish poisoning. Hum Exp Toxicol 20 : 426–428.
  14. Benoit E, 1998. Mechanism of action of neurotoxins acting on the inactivation of voltage-gated sodium channels. C R Seances Soc Biol Fil 192 : 409–436.
  15. Cameron J, Flowers AE, Capra MF, 1991. Electrophysiological studies on ciguatera poisoning in man (Part II). J Neurol Sci 101 : 93–97.
  16. Cameron J, Flowers AE, Capra MF, 1991. Effects of ciguatoxin on nerve excitability in rats (Part I). J Neurol Sci 101 : 87–92.
  17. Molgo J, Benoit E, Mattei C, Legrand AM, 1999. Neuropathology of ciguatera fish poisoning: involvement of voltage-dependent sodium channels. Neuropathol Appl Neurol 25 : 4–5.
  18. Glaziou P, Martin PM, 1993. Study of factors that influence the clinical response to ciguatera fish poisoning. Toxicon 31 : 1151–1154.
  19. Katz AR, Terrell-Perica S, Sasaki DM, 1993. Ciguatera on Kauai: investigation of factors associated with severity of illness. Am J Trop Med Hyg 49 : 448–454.
  20. Coleman AM, 1990. Ciguatoxin-induced food poisoning in a community. Implications for disease surveillance and medical practice in Jamaica. West Indian Med J 39 : 233–238.
  21. De Haro L, Hayek-Lanthois M, Joossen F, Affaton MF, Jouglard J, 1997. Mass ciguatera poisoning after eating barracuda in Mexico: prognostic and therapeutic implications. Med Trop (Mars) 57 : 55–58.
  22. Lindsay J, 1997. Chronic sequelae of foodborne disease. Emerg Infect Dis 3 : 443–452.
  23. Dewailly E, Blanchet C, Gingras S, Sauvé L, Bergeron J, 2001. Effects of omega-3 fatty acids on risk factors of cardiovascular diseases among Indian Crees. Am J Clin Nutr 74 : 464–473.
  24. Crawford MA, Bloom M, Broadhurst CL, Schmidt WF, Scea C, 1999. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 34 : S39–S47.
  25. McKeown-Eyssen GE, Ruedy J, 1983. Prevalence of neurological abnormality in Cree Indians exposed to methylmercury in northern Quebec. Clin Invest Med 6 : 161–169.
  26. Beuter A, de Geoffroy A, Edwards R, 1999. Quantitative analysis of rapid pointing movements in Cree subjects exposed to mercury and in subjects with neurological deficits. Environ Res 80 : 50–63.
  27. Beuter A, Edwards R, De Geoffroy A, Mergler D, Hudnell K, 1999. Quantification of neuromotor function for detection of the effects of manganese. Neurotoxicology 20 : 355–366.
  28. Despres C, Lamoureux D, Beuter A, 2000. Standardization of a neuromotor test battery: the CATSYS system. Neurotoxicology 21 : 725–735.
  29. Bell-Krotoski JA, Fess EE, Figarola JH, Hiltz D, 1995. Threshold detection and Semmes-Weinstein monofilaments. J Hand Ther 8 : 155–162.
  30. Wolfinger R, Chang M, 1995. Comparing the SAS GLM and MIXED Procedures for Repeated Measures. Proceedings of the Twentieth Annual SAS Users Group Conference. Cary, NC: SAS Institute Inc.
  31. Schnorf H, Taurarii M, Cundy T, 2002. Ciguatera fish poisoning: a double-blind randomized trial of mannitol therapy. Neurology 58 : 873–880.
  32. Letz R, Gerr F, 1995. Standing steadiness measurements: empirical selection of testing protocol and outcome measures. Neurotoxicol Teratol 17 : 611–616.
  33. Benoit E, Juzans P, Legrand AM, Molgo J, 1996. Nodal swelling produced by ciguatoxin-induced selective activation of sodium channels in myelinated nerve fibers. Neuroscience 71 : 1121–1131.
  34. Dechraoui MY, Naar J, Pauillac S, Legrand AM, 1999. Ciguatoxins and brevetoxins, neurotoxin polyether compounds active on sodium channels. Toxicon 37 : 125–143.
  35. Gutmann L, 1996. Axonal channelopathies: an evolving concept in the pathogenesis of peripheral nerve disorders. Neurology 47 : 18–21.
  36. Cameron J, Capra MF, 1993. The basis of the paradoxical disturbance of temperature perception in ciguatera poisoning. J Toxicol Clin Toxicol 31 : 571–579.
  37. Beuter A, de Geoffroy A, Edwards R, 1999. Analysis of rapid alternating movements in Cree subjects exposed to methyl mercury and in subjects with neurological deficits. Environ Res 80 : 64–79.
  38. Shinar D, Gross CR, Mohr JP, Caplan LR, Price TR, Wolf PA, Hier DB, Kase CS, Fishman IG, Wolf CL, 1985. Interobserver variability in the assessment of neurologic history and examination in the Stroke Data Bank. Arch Neurol 42 : 557–565.
  39. Edwards R, Beuter A, 1999. Indexes for identification of abnormal tremor using computer tremor evaluation systems. IEEE Trans Biomed Eng 46 : 895–898.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.77.1170
Loading
/content/journals/10.4269/ajtmh.2007.77.1170
Loading

Data & Media loading...

  • Received : 16 Apr 2007
  • Accepted : 18 May 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error